AU533108B2 - Etherfied monosaccharides - Google Patents

Etherfied monosaccharides

Info

Publication number
AU533108B2
AU533108B2 AU44869/79A AU4486979A AU533108B2 AU 533108 B2 AU533108 B2 AU 533108B2 AU 44869/79 A AU44869/79 A AU 44869/79A AU 4486979 A AU4486979 A AU 4486979A AU 533108 B2 AU533108 B2 AU 533108B2
Authority
AU
Australia
Prior art keywords
etherfied
monosaccharides
etherfied monosaccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU44869/79A
Other versions
AU4486979A (en
Inventor
Paul Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alseres Pharmaceuticals Inc
Original Assignee
Strategic Medial Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/424,786 external-priority patent/US3939146A/en
Priority to US05/424,786 priority Critical patent/US3939146A/en
Priority to IN2430/CAL/74A priority patent/IN141230B/en
Priority to DE19742455026 priority patent/DE2455026A1/en
Priority to AU76113/74A priority patent/AU495749B2/en
Priority to AT989874A priority patent/AT352145B/en
Priority to FR7441136A priority patent/FR2254348B2/fr
Priority to GB17502/77A priority patent/GB1497409A/en
Priority to SE7415662A priority patent/SE7415662L/xx
Priority to DD182997A priority patent/DD116029A5/xx
Priority to BE151468A priority patent/BE823313A/en
Priority to CA215,984A priority patent/CA1030960A/en
Priority to GB53972/74A priority patent/GB1497406A/en
Priority to CH1662074A priority patent/CH606073A5/xx
Priority to GB17501/77A priority patent/GB1497408A/en
Priority to GB17500/77A priority patent/GB1497407A/en
Priority to JP14308974A priority patent/JPS5619877B2/ja
Priority to US05/563,080 priority patent/US4056322A/en
Priority to US05/609,724 priority patent/US4017608A/en
Priority to IN496/CAL/1976A priority patent/IN144240B/en
Priority to CA286,998A priority patent/CA1050429A/en
Application filed by Strategic Medial Research Corp filed Critical Strategic Medial Research Corp
Priority to AU44869/79A priority patent/AU533108B2/en
Publication of AU4486979A publication Critical patent/AU4486979A/en
Publication of AU533108B2 publication Critical patent/AU533108B2/en
Application granted granted Critical
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU44869/79A 1973-03-01 1979-03-07 Etherfied monosaccharides Ceased AU533108B2 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
US05/424,786 US3939146A (en) 1973-03-01 1973-12-14 Novel ethereal monosubstitutions of monosaccharide derivatives
IN2430/CAL/74A IN141230B (en) 1973-12-14 1974-11-05
DE19742455026 DE2455026A1 (en) 1973-12-14 1974-11-20 THERAPEUTIC AGENT
AU76113/74A AU495749B2 (en) 1973-12-14 1974-12-05 Therapeutic composition
AT989874A AT352145B (en) 1973-12-14 1974-12-12 PROCESS FOR THE PRODUCTION OF NEW ETHERALLY SUBSTITUTED MONOSACCHARIDE DERIVATIVES AND THE SALT THEREOF
GB17501/77A GB1497408A (en) 1973-12-14 1974-12-13 Method for increasing the life span of tissue culture cells
SE7415662A SE7415662L (en) 1973-12-14 1974-12-13
DD182997A DD116029A5 (en) 1973-12-14 1974-12-13
BE151468A BE823313A (en) 1973-12-14 1974-12-13 NEW THERAPEUTIC COMPOSITION BASED ON MONOSACCHARIDE
CA215,984A CA1030960A (en) 1973-12-14 1974-12-13 Therapeutic composition, novel compounds useful therein, and method of using the same
GB53972/74A GB1497406A (en) 1973-12-14 1974-12-13 Ethereal monosubstitutions of monosaccharide derivatives
CH1662074A CH606073A5 (en) 1973-12-14 1974-12-13
FR7441136A FR2254348B2 (en) 1973-12-14 1974-12-13
GB17500/77A GB1497407A (en) 1973-12-14 1974-12-13 Therapeutic compositions
GB17502/77A GB1497409A (en) 1973-12-14 1974-12-13 Method of therapeutically treating metastatic cancers
JP14308974A JPS5619877B2 (en) 1973-12-14 1974-12-14
US05/563,080 US4056322A (en) 1973-12-14 1975-03-28 Preparation of ethers of monosaccharides
US05/609,724 US4017608A (en) 1973-12-14 1975-09-02 Therapeutic composition and method of therapeutically treating warm blooded animals therewith
IN496/CAL/1976A IN144240B (en) 1973-12-14 1976-03-20
CA286,998A CA1050429A (en) 1973-12-14 1977-09-19 Therapeutic composition, novel compounds useful therein and method of using the same
AU44869/79A AU533108B2 (en) 1973-12-14 1979-03-07 Etherfied monosaccharides

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/424,786 US3939146A (en) 1973-03-01 1973-12-14 Novel ethereal monosubstitutions of monosaccharide derivatives
AU44869/79A AU533108B2 (en) 1973-12-14 1979-03-07 Etherfied monosaccharides
US424786 1989-10-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU76113/74A Division AU495749B2 (en) 1973-12-14 1974-12-05 Therapeutic composition

Publications (2)

Publication Number Publication Date
AU4486979A AU4486979A (en) 1979-07-05
AU533108B2 true AU533108B2 (en) 1983-11-03

Family

ID=25626947

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44869/79A Ceased AU533108B2 (en) 1973-03-01 1979-03-07 Etherfied monosaccharides

Country Status (12)

Country Link
JP (1) JPS5619877B2 (en)
AT (1) AT352145B (en)
AU (1) AU533108B2 (en)
BE (1) BE823313A (en)
CA (1) CA1030960A (en)
CH (1) CH606073A5 (en)
DD (1) DD116029A5 (en)
DE (1) DE2455026A1 (en)
FR (1) FR2254348B2 (en)
GB (4) GB1497407A (en)
IN (2) IN141230B (en)
SE (1) SE7415662L (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0404136A2 (en) * 1989-06-22 1990-12-27 Greenwich Pharmaceuticals Incorporated 3,5,6-Substituted derivatives of 1,2-0-isopropylidene-a,D-glucofuranose and intermediates for preparing these derivatives

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1227276A (en) * 1975-03-28 1977-09-29 Strategic Medical Res Corp Ethers of monosaccarides
DE3812181A1 (en) * 1988-04-13 1989-10-26 Werner E G Prof Dr Mueller MEDICINAL PRODUCTS CONTAINING NATURAL AND / OR CHEMICALLY MODIFIED MONO- OR POLYSACCHARIDES AND THEIR USE
US4996195A (en) * 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US20020165168A1 (en) * 1995-12-16 2002-11-07 Joachim Bunger Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1793336C3 (en) * 1967-09-11 1974-10-03 Ciba-Geigy Ag, Basel (Schweiz) D-glucofuranosides, processes for their production and pharmaceutical preparations containing them
JPS5118195B2 (en) * 1972-06-19 1976-06-08
US3939145A (en) * 1973-03-01 1976-02-17 Strategic Medical Research Corporation Novel ethereally monosubstituted monosaccharides

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0404136A2 (en) * 1989-06-22 1990-12-27 Greenwich Pharmaceuticals Incorporated 3,5,6-Substituted derivatives of 1,2-0-isopropylidene-a,D-glucofuranose and intermediates for preparing these derivatives
EP0404136A3 (en) * 1989-06-22 1992-07-22 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-0-isopropylidene-a,d-glucofuranose and intermediates for preparing these derivatives

Also Published As

Publication number Publication date
GB1497409A (en) 1978-01-12
AT352145B (en) 1979-09-10
DE2455026C2 (en) 1988-02-25
AU4486979A (en) 1979-07-05
FR2254348A2 (en) 1975-07-11
ATA989874A (en) 1979-02-15
JPS5093909A (en) 1975-07-26
DD116029A5 (en) 1975-11-05
GB1497408A (en) 1978-01-12
GB1497406A (en) 1978-01-12
SE7415662L (en) 1975-06-16
BE823313A (en) 1975-06-13
JPS5619877B2 (en) 1981-05-09
FR2254348B2 (en) 1980-03-21
DE2455026A1 (en) 1975-07-03
IN144240B (en) 1978-04-15
CA1030960A (en) 1978-05-09
AU7611374A (en) 1976-06-10
IN141230B (en) 1977-02-05
GB1497407A (en) 1978-01-12
CH606073A5 (en) 1978-10-13

Similar Documents

Publication Publication Date Title
AU474137B2 (en) Auto-refractometer
AU468964B2 (en) Melik
CA1000263A (en) Landing gear
AU498889B2 (en) Piperidylene benzocycloheptathiophenes
AU476397B2 (en) A-cycloalkylbenzyl lactamimides
AU476505B2 (en) Alkylbenxyl lactamimides
AU472907B2 (en) Firecheck
AU533108B2 (en) Etherfied monosaccharides
AU6251473A (en) Dibenzocycloheptenyl lactamimides
AU471241B2 (en) Benzothiazolylureas
AU486380B2 (en) Gear mechanisms
AU482276B2 (en) Spiro-cyclopropanes
AU487916B2 (en) Benzopyranopyridines
AU482530B2 (en) Benzocycloheptathiophenes
AU484993B2 (en) Polyhydroxyphenylchromanones
AU490583B2 (en) 4-aryl-5-aminoalkyl-4-oxazolin-2-ones
AU481998B2 (en) Benzenedisulfonamides
AU485552B2 (en) 2-acyl-4-oxo-pyrazino-isoquinolines
AU486644B2 (en) Fusebox
AU479426B2 (en) Carbothiolates
AU482866B2 (en) Unsymmetrically-substituted-s-triazines
AU489559B2 (en) Amidinoureas
AU492033B2 (en) D-homo-20-keto-pregnanes
AU489560B2 (en) Amidinoureas
AU466103B2 (en) Cis-chrysanthemate